drugset / Trial / NCT05089708
AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle cream in the treatment of moderate acne vulgaris with risk of acne-induced post inflammatory hyperpigmentation (PIH) after 24 weeks of treatment in facial acne participants
Timeline
- Start
- 2021-12-22
- Primary completion
- 2022-12-15
- Completion
- 2022-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trifarotene | Small molecule | 50 unknown | Topical |